UNLOCKD Details Ancient Extracts UK Growth Strategy, Highlighting Strong Economics and International Expansion

By The Building Texas Show•
UNLOCKD Inc. (OTCID: BFCH) outlines the commercial opportunity behind its proposed acquisition of Ancient Extracts UK, emphasizing strong operating metrics and a strategy to scale a combined U.S. and UK wellness platform.

Found this article helpful?

Share it with your network and spread the knowledge!

UNLOCKD Details Ancient Extracts UK Growth Strategy, Highlighting Strong Economics and International Expansion

Texas-based investors and entrepreneurs tracking the consumer wellness space have a new development to watch: UNLOCKD Inc., a publicly traded holding company doing business as UNLOCKD (OTCID: BFCH), has detailed the commercial rationale behind its proposed acquisition of Ancient Extracts Ltd, a British functional wellness business. The announcement, first reported via NEWMEDIAWIRE, follows a binding Letter of Intent signed on November 3 and offers a rare look at the operating economics of a transatlantic wellness roll-up strategy.

Ancient Extracts UK reports approximately $920,000 in annualized revenue, gross margins of roughly 75%, and an established subscription business with about 540 active subscribers generating nearly $240,000 in annualized recurring revenue. Other reported metrics include an average order value of about $44, customer lifetime revenue value of about $200, a returning customer rate of approximately 37%, a Shopify conversion rate of about 3.3%, and a TikTok customer acquisition cost of roughly $5. Management believes these figures demonstrate an attractive operating foundation, particularly the combination of high gross margins, repeat purchasing, and digital acquisition capabilities.

The strategic logic runs deeper than the metrics. John P. Gorst, now CEO of UNLOCKD, previously established Ancient Extracts USA through VerdaGenix, LLC, and the relationship with the UK business included a conditional contractual right to pursue an acquisition. UNLOCKD acquired Ancient Extracts USA in May 2026, and in July, Ancient Extracts UK Co-Founder Jamie Jarrett joined UNLOCKD's Board of Directors. Gorst framed the deal as an execution play rather than a startup bet. "This is not a business we have to build from zero," he said. "Ancient Extracts UK already has revenue, customers, subscriptions, products, and digital marketing infrastructure."

For Texas, the implications center on the state's growing role as a hub for consumer health and wellness companies. UNLOCKD's portfolio, which includes Ancient Extracts USA, EVERMIND, and 1ENERGY, is part of a broader transformation since a July 2025 change in control. Management has focused on restructuring legacy obligations and acquiring differentiated wellness businesses. The company's long-term objective is to build a consumer health and wellness company capable of generating $100 million or more in annual revenue, an aspirational target rather than a forecast. If successful, the combined U.S.-UK platform could coordinate product development, customer acquisition, subscription growth, and distribution across both markets, with the UK infrastructure potentially supporting future European expansion.

The broader market context is notable. Third-party estimates have placed annual revenue for RYZE above $300 million, Everyday Dose at approximately $100 million, and Four Sigmatic above $50 million, illustrating the commercial scale achievable in functional coffee and wellness. While UNLOCKD has not verified these estimates and the companies differ materially from Ancient Extracts, the figures suggest room for a well-positioned challenger. More information about the company is available at https://unlockdinc.com/, and the full release can be viewed at www.newmediawire.com.

Closing remains subject to qualifying financing, completion of an acceptable financial audit, satisfactory due diligence, required approvals, and execution of definitive agreements. There can be no assurance the acquisition will be completed. The metrics attributed to Ancient Extracts UK are preliminary, management-provided, and unaudited, and annualized figures are extrapolations of recent monthly results. Still, for Texas businesses eyeing international expansion, the deal offers a case study in using a U.S. base to scale an established overseas operation rather than building from scratch.